PTEN and colorectal carcinoma: To discover PTEN synthetic lethal targets in PTEN specific context, we previously established PTEN-isogenic HCT116 and DLD1 CRC cell lines using CRISPR/Cas9 gene knockout and conducted synthetic lethal drug screen with the 318 highly selective small molecule inhibitors for over 100 druggable targets 12.